Apogee Therapeutics Inc
(APGE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -12,525 | -39,785 | -25,778 | -6,121 |
| Accounts payable and accrued liabilities | 477 | N/A | 36 | 1,114 |
| Other Working Capital | 694 | 9,815 | 7,702 | 4,433 |
| Other Operating Activity | 797 | 13,543 | 10,802 | 574 |
| Operating Cash Flow | $-10,557 | $-16,427 | $-7,238 | $0 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 168,317 | 9,821 | 4,974 |
| Financing Cash Flow | $0 | $168,317 | $9,821 | $4,974 |
| Beginning Cash Position | 151,890 | 0 | N/A | 0 |
| End Cash Position | 141,333 | 151,890 | 2,583 | 4,974 |
| Net Cash Flow | $-10,557 | $151,890 | $2,583 | $4,974 |
| Free Cash Flow | ||||
| Operating Cash Flow | -10,557 | -16,427 | -7,238 | 0 |
| Free Cash Flow | -10,557 | -16,427 | -7,238 | 0 |